New treatments for mesothelioma are currently on the rise while clients await legal results. One of the newer treatments for mesothelioma involves a study related to the body’s genes and metastasis, or the transfer of the disease to other parts of the body. Doctors have found that metastasis is the cause of nearly 90 percent of cancer deaths. Therefore, doctors have focused on treatments that could stop metastasis of the disease.
Epigenetics is the study of changes in gene expression. It looks at active versus inactive genes and alterations that do not involve changes to the underlying DNA present in the gene. Turning genes “on” or “off” can alter how cells around the gene interact with the gene. Epigenetic changes are natural, but these changes can also be influenced by environment, age, diet and lifestyle. Epigenetic changes can also result in diseases like cancer.
Although human epigenetic marks are more stable during adulthood, there is still room for change to our genes due to lifestyle choices. For example, air pollution can alter tags on adult DNA, and B vitamins may protect humans from these effects. Diet can also modify epigenetic tags. High fat and low carb diets could improve mental abilities that are seen through HDAC inhibitors in our genes. Certain foods can also protect against cancer and toxins in the environment.
Researchers have discovered novel ways to turn genes on and off as a way for the body to tell the difference between primary tumors and metastatic tumors. Preliminary studies involving cells from animals show that this type of work could prevent mesothelioma cancer from metastasizing from the lungs into other areas of the body.
The findings suggest that an altered gene-enhancer activity is what drives the cancer cell’s ability to metastasize in the body. Researchers in a study at Case Western Reserve University School of Medicine in Cleveland, Ohio found that there were “bunched clusters of enhancers” very close to the cancer cells that had metastasized to the lungs. These enhancers can be interrupted with BET inhibitor drugs, and researchers found in mice that they were able to slow down the cancer growth in the lungs. Although more research is needed, BET inhibitors are a promising gene-related class of anti-cancer drugs now in clinical trials.
Halting the growth of the cancer to other areas of the body could be a major breakthrough. This could increase the survival of the nearly 3,000 Americans diagnosed with mesothelioma each year. This could also be a breakthrough for the treatment of other types of cancers as well.
If you have been diagnosed with mesothelioma, our Philadelphia mesothelioma lawyers at Brookman, Rosenberg, Brown & Sandler have represented mesothelioma patients and others experiencing asbestos-related illnesses. Let us assist you in obtaining the compensation you need and deserve. We are centrally located in Philadelphia, Pennsylvania, and we proudly serve clients from the surrounding areas. To set up a free initial consultation, complete our online form or call us at 215-569-4000 today.